Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Hospitalist · FRESNO, CA · NPI 1548269707
Verified facts
CMS Open Payments records show Pawan K Sood, M.D. received $29.15 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $29.15 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $29.15 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $29.15 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1895 | 155 |
| Amlodipine Besylate | Amlodipine Besylate | 946 | 70 |
| Levothyroxine Sodium | Levothyroxine Sodium | 893 | 81 |
| Gabapentin | Gabapentin | 794 | 69 |
| Metoprolol Succinate | Metoprolol Succinate | 661 | 50 |
| Metoprolol Tartrate | Metoprolol Tartrate | 657 | 52 |
| Pantoprazole Sodium | Pantoprazole Sodium | 629 | 69 |
| Furosemide | Furosemide | 590 | 62 |
| Eliquis | Apixaban | 578 | 57 |
| Metformin Hcl | Metformin Hcl | 536 | 40 |
| Losartan Potassium | Losartan Potassium | 530 | 36 |
| Tamsulosin Hcl | Tamsulosin Hcl | 495 | 41 |
| Lisinopril | Lisinopril | 468 | 41 |
| Carvedilol | Carvedilol | 447 | 35 |
| Mirtazapine | Mirtazapine | 405 | 26 |
| Clopidogrel | Clopidogrel Bisulfate | 342 | 36 |
| Famotidine | Famotidine | 330 | 25 |
| Potassium Chloride | Potassium Chloride | 303 | 36 |
| Donepezil Hcl | Donepezil Hcl | 295 | 23 |
| Finasteride | Finasteride | 289 | 15 |
| Sertraline Hcl | Sertraline Hcl | 278 | 21 |
| Levetiracetam | Levetiracetam | 262 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 258 | 22 |
| Omeprazole | Omeprazole | 244 | 26 |
| Escitalopram Oxalate | Escitalopram Oxalate | 205 | 13 |
| Clonidine Hcl | Clonidine Hcl | 203 | 16 |
| Divalproex Sodium | Divalproex Sodium | 191 | 11 |
| Myrbetriq | Mirabegron | 188 | 11 |
| Xarelto | Rivaroxaban | 184 | 11 |
| Simvastatin | Simvastatin | 171 | 16 |
| Buspirone Hcl | Buspirone Hcl | 169 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 163 | 19 |
| Hydrochlorothiazide | Hydrochlorothiazide | 152 | 11 |
| Allopurinol | Allopurinol | 149 | 14 |
| Spironolactone | Spironolactone | 149 | 15 |
| Nifedipine Er | Nifedipine | 145 | suppressed |
| Olanzapine | Olanzapine | 132 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 130 | 30 |
| Pioglitazone Hcl | Pioglitazone Hcl | 124 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 124 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 118 | 21 |
| Tradjenta | Linagliptin | 118 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 115 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 110 | 27 |
| Risperidone | Risperidone | 109 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 108 | suppressed |
| Jardiance | Empagliflozin | 108 | 12 |
| Celecoxib | Celecoxib | 107 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 106 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 105 | suppressed |
| Digoxin | Digoxin | 103 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 102 | 23 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 100 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 100 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 98 | 16 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 97 | 28 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 97 | 12 |
| Glipizide | Glipizide | 92 | suppressed |
| Aripiprazole | Aripiprazole | 82 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 81 | 15 |
| Methimazole | Methimazole | 78 | suppressed |
| Bupropion Xl | Bupropion Hcl | 77 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 77 | 12 |
| Divalproex Sodium Er | Divalproex Sodium | 73 | suppressed |
| Latanoprost | Latanoprost | 67 | 14 |
| Calcium Acetate | Calcium Acetate | 66 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 65 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 64 | suppressed |
| Nyamyc | Nystatin | 63 | 20 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 61 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 60 | 13 |
| Creon | Lipase/Protease/Amylase | 58 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 58 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 57 | suppressed |
| Amantadine | Amantadine Hcl | 55 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 55 | suppressed |
| Lorazepam | Lorazepam | 55 | suppressed |
| Metronidazole | Metronidazole | 54 | suppressed |
| Glimepiride | Glimepiride | 53 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 53 | 12 |
| Benztropine Mesylate | Benztropine Mesylate | 48 | suppressed |
| Enulose | Lactulose | 48 | suppressed |
| Memantine Hcl | Memantine Hcl | 48 | suppressed |
| Entresto | Sacubitril/Valsartan | 47 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 47 | suppressed |
| Pentasa | Mesalamine | 47 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 46 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 46 | suppressed |
| Folic Acid | Folic Acid | 45 | suppressed |
| Methocarbamol | Methocarbamol | 42 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 42 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 42 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 42 | 13 |
| Benazepril Hcl | Benazepril Hcl | 40 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 40 | suppressed |
| Sucralfate | Sucralfate | 40 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 39 | suppressed |
| Atenolol | Atenolol | 38 | suppressed |
| Meloxicam | Meloxicam | 38 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 37 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 34 | suppressed |
| Ezetimibe | Ezetimibe | 33 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 30 | 18 |
| Dutasteride | Dutasteride | 30 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 29 | suppressed |
| Prednisone | Prednisone | 29 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 29 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 29 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 27 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 26 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 26 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 26 | suppressed |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Glipizide Er | Glipizide | 25 | suppressed |
| Humulin R | Insulin Regular, Human | 25 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 25 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 24 | suppressed |
| Repaglinide | Repaglinide | 24 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 23 | suppressed |
| Lactulose | Lactulose | 23 | suppressed |
| Leflunomide | Leflunomide | 23 | suppressed |
| Ranolazine Er | Ranolazine | 23 | suppressed |
| Clonazepam | Clonazepam | 22 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 22 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 21 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 21 | suppressed |
| Ramipril | Ramipril | 21 | suppressed |
| Dofetilide | Dofetilide | 20 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 19 | suppressed |
| Cephalexin | Cephalexin | 19 | 16 |
| Levofloxacin | Levofloxacin | 19 | 16 |
| Bupropion Hcl | Bupropion Hcl | 18 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | 13 |
| Nitroglycerin | Nitroglycerin | 18 | suppressed |
| Imatinib Mesylate | Imatinib Mesylate | 17 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 17 | suppressed |
| Baclofen | Baclofen | 16 | suppressed |
| Bicalutamide | Bicalutamide | 16 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 16 | 13 |
| Morphine Sulfate Er | Morphine Sulfate | 16 | suppressed |
| Permethrin | Permethrin | 16 | suppressed |
| Bumetanide | Bumetanide | 15 | suppressed |
| Pregabalin | Pregabalin | 14 | suppressed |
| Alprazolam | Alprazolam | 13 | suppressed |
| Azithromycin | Azithromycin | 13 | 12 |
| Humalog | Insulin Lispro | 13 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Nystatin | Nystatin | 13 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 13 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Haloperidol | Haloperidol | 12 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 12 | suppressed |
| Levalbuterol Hcl | Levalbuterol Hcl | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $29.15 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error